Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.
about
Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?Association between Long Interspersed Nuclear Element-1 Methylation and Relative Telomere Length in Wilms TumorDysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia.Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.Telomere status in chronic lymphocytic leukemia with TP53 disruption.Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic LeukemiaHypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases.3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolution.Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A.Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemiaAlterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemiaIdentifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma.Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions.Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair.
P2860
Q26738706-8D1F6F57-BB71-4FCC-A1A3-A5EEE0A74E1FQ28389928-8FD8976B-BCD4-4EA8-805C-A3B313AA6B76Q33860001-1F3C73BC-8A29-4B57-8CBA-364729C8266AQ35772403-6EAD818D-6A23-4E8C-8C49-E9F4C02E78A8Q36093789-11C86503-7781-49C3-90F2-BDE272A55675Q37225819-9EF8551C-A446-40C9-8170-F8874993CA6FQ40341051-18321F7E-97D4-40F8-864D-4E2C45C89AE0Q40485655-F4773AFA-441A-4D61-8D02-478A5998628CQ42042759-5343D097-D36C-41D1-A3C4-E6DB6290C2F3Q42250056-95167233-6C1C-4DA0-BE81-39AF617178C8Q42348459-1EE6638A-1DA7-417C-99CC-AAE8D10C39FEQ42371573-E73463C5-C579-4CFD-A955-EB41E793EA4DQ47635411-38C165AF-CB78-4961-9DF9-FCB04D833874Q50900368-75F84197-E409-49F5-8A0D-BC7A751099EDQ52941092-EF1EEA27-D0BA-4F09-9B66-2A85504A7C04Q54980026-D32311A1-310E-44D3-81E2-1E3EF2160EDD
P2860
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Relevance of telomere/telomera ...... chronic lymphocytic leukemia.
@ast
Relevance of telomere/telomera ...... chronic lymphocytic leukemia.
@en
type
label
Relevance of telomere/telomera ...... chronic lymphocytic leukemia.
@ast
Relevance of telomere/telomera ...... chronic lymphocytic leukemia.
@en
prefLabel
Relevance of telomere/telomera ...... chronic lymphocytic leukemia.
@ast
Relevance of telomere/telomera ...... chronic lymphocytic leukemia.
@en
P2093
P2860
P50
P356
P1476
Relevance of telomere/telomera ...... chronic lymphocytic leukemia.
@en
P2093
Fortunato Morabito
Luca Agnelli
Massimo Gentile
Serena Matis
P2860
P304
P356
10.1002/GCC.22171
P50
P577
2014-04-04T00:00:00Z